–MS CSF: strong/moderate CHI3L1 correlations with NfL, GFAP, MMP-9, OPN, CXCL1, CXCL8, CXCL10, CXCL13, and CCL22–MS serum: no biomarker differences. This evidence concerns the gene CCL22 and myeloid sarcoma.